Every Form 4 that Bausch + Lomb Corporation (BLCO) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow BLCO and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BLCO filings page.
Trebbi Barbara reported acquisition or exercise transactions in this Form 4 filing.
Bausch & Lomb Corp director Barbara Trebbi received an equity compensation award on 2026-08-12. She was granted 11,776 restricted share units (RSUs) under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. The RSUs are scheduled to vest immediately before the conclusion of the next annual meeting of shareholders and will be settled in common shares, resulting in direct ownership of 11,776 common shares after the award.
Bausch & Lomb Corp director Laurence E. Paul reported an acquisition of 11,776 Common Shares on 2026-08-12 through an annual grant of restricted share units (RSUs) for non-employee directors under the 2022 Omnibus Incentive Plan. These RSUs are scheduled to vest immediately before the next annual meeting of shareholders and will be settled in common shares upon vesting. Following this grant, Paul directly holds 11,776 common shares.
Chersi Robert J reported acquisition or exercise transactions in this Form 4 filing.
Bausch & Lomb Corp director Robert J. Chersi received an equity compensation award of 11,776 restricted share units (RSUs) of common shares under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. The RSUs will vest immediately before the conclusion of the next annual meeting of shareholders and are then settled in common shares. After this grant, Chersi directly holds 11,776 common shares.
Bausch & Lomb Corp executive Frederick Munsch, SVP, Controller and CAO, reported a sale of 52,900 Common Shares on August 10, 2026 in an open-market or private transaction at a weighted average price of $16.78 per share. The shares were sold in multiple trades between $16.73 and $16.85 per share, leaving him with 45,831 Common Shares held directly after the transaction.
Bausch & Lomb Corp director Andrew C. Von Eschenbach reported two open-market sales of common shares. On August 6, 2026, he sold 12,500 shares at a weighted average price of $16.50, with individual trades ranging from $16.43 to $16.54. On August 7, 2026, he sold 6,059 shares at a weighted average price of $16.58, with trades from $16.57 to $16.60. A footnote also states that 4,364 matching restricted share units were forfeited to the issuer for no consideration in connection with his resignation from the board on August 5, 2026.
Stewart Andrew J. reported acquisition or exercise transactions in this Form 4 filing.
Bausch & Lomb Corp reported that President, GPIC Andrew J. Stewart received an equity award tied to performance. On August 5, 2026, 16,778 common shares underlying previously granted performance stock units were earned at the 100% target level. These PSUs will vest on February 28, 2027, generally conditioned on continued employment, bringing his direct holdings to 103,211 shares.
Munsch Frederick reported acquisition or exercise transactions in this Form 4 filing.
Bausch & Lomb Corp SVP, Controller and CAO Frederick Munsch reported an equity award tied to 9,091 common shares at a stated price of $0.00 per share, reflecting performance stock units that met 100% of target conditions as of August 5, 2026. These earned PSUs are scheduled to vest on February 28, 2027, subject to continued employment, bringing his directly held common shares to 98,731.
Bausch & Lomb Corp executive Yehia Hashad, EVP of R&D and CMO, reported an acquisition of 20,973 Common Shares at a stated price of $0.00 per share. According to the footnote, these represent common shares underlying performance stock units granted on February 28, 2024 that achieved the target performance level (100%) as of August 5, 2026. The earned PSUs will vest on February 28, 2027, generally subject to his continued employment, bringing his direct holdings to 187,350 shares. The Rule 10b5-1 trading plan checkbox was not marked.
Bausch & Lomb EVP and CFO Sam Eldessouky reported an award of 50,335 common shares at $0.00 per share, representing shares underlying performance stock units granted on February 28, 2024. After this acquisition he directly holds 393,527 common shares. The earned PSUs will vest on February 28, 2027, subject to his continued employment.
Bausch & Lomb executive Luc Bonnefoy, President, Surgical, reported acquiring 16,778 common shares linked to performance stock units under the 2022 Omnibus Incentive Plan. The PSUs achieved their 100% target performance level as of August 5, 2026 and will vest on February 28, 2027, subject to continued employment. Following this award, Bonnefoy holds 103,801 common shares directly.
Robert D. Bailey, EVP & Chief Legal Officer of Bausch & Lomb Corp, reported a grant/award acquisition of 33,557 common shares underlying performance stock units that earned at 100% of target as of August 5, 2026. These PSUs will vest on February 28, 2027, increasing his direct holdings to 264,241 shares, subject to continued employment.
Bausch & Lomb Corp Chairman and CEO Brent L. Saunders reported two equity-related transactions dated August 5, 2026. The company withheld 4,231 common shares at $16.76 per share to satisfy tax withholding obligations upon vesting of restricted share units. Saunders was also credited with 281,879 common shares underlying performance stock units originally granted on February 28, 2024 that achieved the 100% target performance level as of August 5, 2026; these earned PSUs are scheduled to vest on February 28, 2027, subject to his continued employment. These transactions were not reported as made under a Rule 10b5-1 trading plan.
Bausch & Lomb Corp executive Luc Bonnefoy reported a routine tax-withholding transaction related to equity compensation. On the vesting of restricted share units, 1,008 common shares were withheld at an indicated value of $15.08 per share to satisfy tax obligations. After this non-market disposition, Bonnefoy directly holds 87,023 common shares.
VON ESCHENBACH ANDREW C. reported acquisition or exercise transactions in this Form 4 filing.
Bausch & Lomb Corp director Andrew C. Von Eschenbach received an annual equity grant of 15,842 common shares, reported as a grant or award at $15.78 per share. The award reflects restricted share units granted under the company’s 2022 Omnibus Incentive Plan and is scheduled to vest before the next annual shareholder meeting, bringing his direct holdings to 86,656 common shares.
Bausch & Lomb Corporation director Ross Thomas W. Sr. reported an acquisition of 15,842 common shares tied to a new equity award. The filing shows this as a grant of restricted share units (RSUs) under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated.
The RSUs are scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders and will be settled in common shares. After this grant, Ross directly holds 85,233 common shares, indicating this is a routine annual equity award for a non-employee director rather than an open-market purchase.
ROBERTSON RUSSEL C reported acquisition or exercise transactions in this Form 4 filing.
Bausch & Lomb Corp director Russel C. Robertson received an equity award rather than buying shares on the market. He was granted 15,842 common shares at $15.78 per share as part of his annual restricted share unit (RSU) grant for non-employee directors.
Following this grant, he directly holds 94,260 common shares. The RSUs are scheduled to vest immediately before the company’s next annual meeting of shareholders and will then be settled in common shares under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan.
Bausch & Lomb Corp director John Paulson reported receiving a stock-based compensation award rather than making an open-market trade. He acquired 15,842 common shares at an accounting value of $15.78 per share through a grant of restricted share units under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan.
Following this award, his direct holdings rose to 89,823 common shares. The RSUs are scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders and will be settled in common shares when vested.
Ling Karen reported acquisition or exercise transactions in this Form 4 filing.
Bausch & Lomb Corp director Karen Ling received an equity grant rather than buying shares on the market. She was awarded 15,842 common shares at a reference price of $15.78 per share as part of her annual restricted share unit (RSU) grant for non-employee directors. Following this award, she directly holds 61,518 common shares. The RSUs are scheduled to vest immediately before the conclusion of the next annual meeting of shareholders, when they will be settled in common shares.
KAVANAGH SARAH B reported acquisition or exercise transactions in this Form 4 filing.
Bausch & Lomb Corp director Sarah B. Kavanagh received an equity grant of 15,842 common shares-equivalent on an award date price of $15.78 per share. The grant reflects annual restricted share units for non-employee directors under the company’s 2022 Omnibus Incentive Plan.
The RSUs are scheduled to vest immediately before the conclusion of the next annual meeting of shareholders and will be settled in common shares. Following this award, Kavanagh directly holds 69,541 common shares, highlighting this as compensation-related rather than an open-market purchase.
COLLIS STEVEN H reported acquisition or exercise transactions in this Form 4 filing.
Bausch & Lomb Corp director Steven H. Collis received an equity award rather than buying shares on the market. He was granted 15,842 common-share-equivalent restricted share units (RSUs) valued at $15.78 per unit, bringing his direct holdings to 42,003 common shares after the award.
The RSUs were granted as the annual award to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. They are scheduled to vest on the date immediately before the company’s next annual meeting of shareholders, when they will be settled in common shares.
Bernier Nathalie D. reported acquisition or exercise transactions in this Form 4 filing.
Bausch & Lomb Corp director Nathalie D. Bernier received an annual equity award in the form of restricted share units (RSUs). She was granted 15,842 common shares at a reference price of $15.78 per share, increasing her direct holdings to 85,505 common shares.
The footnote explains this is the regular annual RSU grant to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. These RSUs will vest immediately before the next annual meeting of shareholders and will then be settled in common shares.
Alfonso Eduardo reported acquisition or exercise transactions in this Form 4 filing.
Bausch & Lomb Corp director Alfonso Eduardo received an equity award linked to 15,842 common shares of the company. The Form 4 shows this as a grant or award, not an open-market purchase, at a reference price of $15.78 per share. This reflects his annual grant of restricted share units under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan for non-employee directors. The RSUs will be settled in common shares and are scheduled to vest immediately before the conclusion of the next annual meeting of shareholders. Following this award, Eduardo directly holds 31,072 common shares.
Bausch & Lomb Corp Chairman and CEO Brent L. Saunders reported a routine tax-related share disposition. On May 22, 2026, 2,886 common shares at $15.92 per share were withheld to satisfy tax withholding obligations upon vesting of restricted share units. After this non-market transaction, Saunders directly holds 978,389 common shares, so the withheld amount represents only a small portion of his overall position.
Bausch & Lomb Corp EVP and CFO Sam Eldessouky reported a tax-related share disposition. On May 5, 2026, 63,938 common shares were withheld at $16.00 per share to satisfy tax withholding obligations upon vesting of restricted share units. This was not an open-market sale. After this withholding, Eldessouky directly holds 343,192 common shares of Bausch & Lomb Corp.
Bausch & Lomb Corp executive Yehia Hashad, EVP of R&D and CMO, reported a routine tax-related share disposition on Form 4. On May 5, 2026, 13,664 common shares at $16.00 per share were withheld to cover tax obligations triggered by the vesting of restricted share units, rather than sold in the open market. After this withholding, Hashad directly holds 166,377 common shares, indicating he retains a substantial equity stake in the company.
Bausch & Lomb Corp senior vice president, controller and chief accounting officer Frederick Munsch reported a routine share disposition related to taxes. On May 5, 2026, 8,673 Common Shares at $16.00 per share were withheld to cover tax obligations upon vesting of restricted share units, rather than sold on the open market.
After this tax-withholding event, Munsch directly holds 89,640 Common Shares. The filing reflects a compensation-related withholding, not an open-market purchase or sale decision.
Bausch & Lomb Corp executive Luc Bonnefoy, President of Surgical, reported a routine tax-related share disposition. On the vesting of restricted share units, 11,970 common shares were withheld by the company to satisfy tax withholding obligations, rather than sold on the open market. Following this withholding, Bonnefoy directly holds 88,031 common shares, showing he retains a substantial equity position after the RSU vesting event.
ROBERTSON RUSSEL C reported acquisition or exercise transactions in this Form 4 filing.
Bausch & Lomb Corp director Russel C. Robertson received an equity award of 1,611 common shares on April 30, 2026. The filing describes these as restricted share units, each representing a contingent right to receive one common share of Bausch & Lomb.
After this grant, Robertson directly holds 78,418 common shares. This is a compensation-related grant, not an open-market purchase, and reflects additional alignment of the director’s interests with common shareholders through stock-based awards.
Bausch & Lomb Corp director John Paulson received an equity grant. He acquired 1,375 restricted share units, each representing a contingent right to receive one common share of Bausch & Lomb, at a reference price of $15.90 per share.
Following this grant, Paulson directly holds 73,981 common shares. This is a compensation-related award reported as an acquisition, not an open-market purchase or sale.
Bausch & Lomb Corp director Steven H. Collis received a grant of restricted share units in the company. On this award date, he acquired 1,415 restricted share units, each representing a contingent right to receive one common share of Bausch & Lomb. Following this award, his directly held common share-equivalent position reported in this filing is 26,161 shares.
Bausch & Lomb Corp director Alfonso Eduardo reported an acquisition of 1,375 common shares on April 30, 2026 through a grant of restricted share units. Each unit represents a contingent right to receive one common share at a reference price of $15.90 per share.
After this compensation-related award, Eduardo directly holds 15,230 common shares. This filing reflects an equity grant rather than an open-market purchase or sale, and does not involve any derivative exercises.
Bausch & Lomb Corp President, GPIC Andrew J. Stewart reported a routine tax-withholding share disposition. On the vesting of restricted share units, 4,216 common shares were withheld at $15.82 per share to cover tax obligations. After this non-market transaction, he holds 86,433 common shares directly.
Bausch & Lomb Corp executive Robert D. Bailey, EVP & Chief Legal Officer, reported a routine tax-related share disposition. On this Form 4, 15,806 common shares were withheld at $15.82 per share to cover tax withholding obligations from vesting restricted share units. Following this withholding, Bailey directly holds 230,684 common shares, indicating this was not an open-market sale but a standard mechanism to satisfy taxes due at vesting.
Bausch & Lomb Corp executive Robert D. Bailey, EVP & Chief Legal Officer, reported new activity in company stock. On March 6, 2026, he made an open-market purchase of 14,600 common shares at an average price of $17.146 per share, held in his self-directed IRAs.
In connection with this purchase, he also acquired 14,600 matching restricted share units (MRSUs) under the company’s matching share program. These MRSUs vest in three equal annual installments over three years, contingent on his continued service, bringing his direct holdings to 246,490 common shares after the reported transactions.
Bausch & Lomb Corp Executive Vice President and CFO Sam Eldessouky reported new insider activity in common shares. He made an open-market purchase of 4,000 common shares at $17.13 per share, increasing his direct ownership.
In connection with this purchase, he was also granted 4,000 matching restricted share units (MRSUs) under the company’s matching share program. One-third of these MRSUs will vest on each of the first, second, and third anniversaries of the grant date, subject to his continued service. Following these transactions, he directly holds 407,130 common shares.
Bausch & Lomb Corp CEO and Chairman Brent L. Saunders reported buying 14,700 common shares in an open-market transaction at a weighted average price of about $17.14 per share, with trade prices ranging from $17.09 to $17.19. He also received 14,700 matching restricted share units under the company’s matching share program, which vest in three equal annual installments if he continues in service. Following these transactions, he directly holds 981,275 common shares.
Bausch & Lomb Corp director Ross Thomas W. Sr. reported two transactions in common shares. He made an open-market purchase of 4,500 common shares at a weighted average price of $17.679 per share, increasing his direct holdings to 64,891 shares immediately after the trade. In connection with this purchase, he also acquired 4,500 matching restricted share units (MRSUs) under the company’s matching share program, bringing his total reported direct holdings to 69,391 shares. One-third of these MRSUs will vest on each of the first, second, and third anniversaries of the grant date, subject to his continued service, with limited exceptions.
Bausch & Lomb Corp director Alfonso Eduardo increased his stake through an open-market purchase and a related equity award. He bought 4,300 common shares at a price of $17.90 per share, bringing his directly held shares to 9,555 immediately after the purchase.
In connection with this purchase and under the company’s matching share program, he was granted 4,300 matching restricted share units, which raised his total direct holdings to 13,855 common shares. One-third of these matching restricted share units will vest on each of the first, second, and third anniversaries of the grant date, subject to his continued service, apart from limited circumstances.
Bausch & Lomb Corp director Andrew C. Von Eschenbach reported two transactions in common shares. He made an open-market purchase of 4,364 shares at $18.305 per share, increasing his direct holdings to 66,450 shares. In connection with this purchase, he also received a grant of 4,364 matching restricted share units under the company’s matching share program, which will vest in three equal installments on each of the first, second, and third anniversaries of the grant date, subject to his continued service.
Bausch & Lomb Corp senior vice president, controller and chief accounting officer Frederick Munsch reported multiple share dispositions related to tax withholding. On February 27, he disposed of 2,437 and 5,692 common shares at $18.30 per share through tax-withholding transactions. On February 26, he disposed of an additional 2,042 common shares at $18.49 per share, also for tax withholding.
According to the footnotes, these shares were withheld to cover tax obligations due upon the vesting of restricted share units and performance-based restricted share units, rather than being discretionary open-market sales.
Bausch & Lomb Corp executive Andrew J. Stewart reported tax-related share dispositions tied to vesting of restricted share units. On February 26, he had 2,984 common shares withheld at $18.49 per share to cover tax obligations, leaving 92,656 common shares owned directly afterward.
On February 27, an additional 2,007 common shares were withheld at $18.30 per share for the same purpose, leaving him with 90,649 directly owned common shares following this transaction. These Form 4 entries reflect tax-withholding dispositions rather than open-market purchases or sales.
Bausch & Lomb Corp executive Luc Bonnefoy, President of Surgical, reported tax-related dispositions of common shares tied to equity awards. On February 26, 2026, 4,404 common shares at $18.49 per share were withheld to cover tax obligations upon vesting of restricted share units, leaving 113,533 shares held directly.
On February 27, 2026, 4,311 common shares and 9,221 common shares, each at $18.30 per share, were similarly withheld to satisfy tax liabilities on vesting of restricted and performance-based restricted share units, leaving 109,222 and 100,001 common shares, respectively, held directly after these transactions.
Bausch & Lomb Corp executive Yehia Hashad reported tax-related share dispositions. On February 26–27, he had several Form 4 transactions coded "F," where common shares were withheld at prices around $18.30–$18.49 to cover tax obligations upon vesting of restricted and performance-based restricted share units. After one February 27 transaction, he held 180,041 common shares directly.
Bausch & Lomb Corp executive Robert D. Bailey reported routine share dispositions related to tax withholding on vested equity awards. On two dates, he surrendered 3,395 and 2,461 common shares, respectively, at prices of $18.49 and $18.30 per share to cover tax obligations on restricted share unit vesting, rather than selling shares on the open market. After these tax-withholding transactions, he directly holds 217,290 common shares.
Bausch & Lomb EVP and CFO Sam Eldessouky reported tax-withholding dispositions of common shares related to equity awards. On February 26–27, 2026, he delivered 15,507, 51,470 and 7,062 common shares at prices of $18.30 and $18.49 per share to satisfy tax obligations.
Footnotes explain these shares were withheld upon vesting of restricted share units and performance-based restricted share units, rather than sold in open-market transactions. Eldessouky retains a significant direct holding of Bausch & Lomb common shares after these tax-withholding events.
Bausch & Lomb Corp CEO and Chairman Brent L. Saunders reported two Form 4 transactions reflecting common shares withheld to cover taxes on restricted share units that vested. On February 26, 22,059 common shares at $18.49 per share were withheld. On February 27, an additional 24,649 common shares at $18.30 per share were withheld. These are coded as tax-withholding dispositions rather than open-market sales, and Saunders held 951,875 common shares directly after the most recent transaction.
Munsch Frederick reported acquisition or exercise transactions in this Form 4 filing.
Bausch & Lomb Corporation Senior Vice President, Controller and Chief Accounting Officer Frederick Munsch received an equity award of 18,253 common shares in the form of restricted share units. The grant was made at no cash cost to him as part of the company’s 2022 Omnibus Incentive Plan.
The RSUs are scheduled to vest in three equal installments on each of the first three anniversaries of the grant date, subject to his continued service and the plan and award agreement terms. After this award, he beneficially owns 108,484 common shares directly.
Bausch & Lomb Corp reported that President, Surgical, Luc Bonnefoy acquired 30,373 common shares through a grant of restricted share units (RSUs) at no cost per share. These RSUs vest one-third on each of the first three anniversaries of the grant date. After this award, Bonnefoy holds 117,937 common shares directly.
Bausch & Lomb Corp reported that executive Andrew J. Stewart, President, GPIC, acquired 32,710 common shares on February 25, 2026 through a grant of restricted share units (RSUs) at $0.00 per share. After this award, he holds 95,640 common shares directly.
The RSUs vest in three equal installments on each of the first three anniversaries of the grant date, generally contingent on his continued service. Once vested, these RSUs will be settled in Bausch & Lomb common shares.
Hashad Yehia reported acquisition or exercise transactions in this Form 4 filing.
Bausch & Lomb Corp executive Yehia Hashad, EVP of R&D and CMO, received a grant of 35,046 restricted share units (RSUs) on common shares at a price of $0.00 per share. After this equity award, his directly held common shares total 198,906.
The RSUs were granted under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan and are scheduled to vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to continued service and plan terms. Vested RSUs will be settled in common shares of Bausch & Lomb.